UNH - UnitedHealth Group Incorporated
| Previous Close | 234.43 |
| Open | 233.07 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's Range | 231.17 - 233.99 |
| 52 Week Range | 208.07 - 287.94 |
| Volume | 2,036,230 |
| Avg. Volume | 3,741,864 |
| Market Cap | 220.355B |
| Beta (3Y Monthly) | 0.70 |
| PE Ratio (TTM) | 17.47 |
| EPS (TTM) | 13.31 |
| Earnings Date | Oct 14, 2019 - Oct 18, 2019 |
| Forward Dividend & Yield | 4.32 (1.84%) |
| Ex-Dividend Date | 2019-09-13 |
| 1y Target Est | 294.58 |
- Morningstar
13 Stocks to Own
In Steal Like an Artist, author (and artist) Austin Kleon argues that nothing is completely original--we learn by copying. Kleon isn't suggesting that plagiarism is OK. Rather, he tells readers that they should collect good ideas and allow themselves to be influenced by them.
- Business Wire
America’s Health Rankings Health of Women and Children Report Shows Nationwide Increase in Teen Suicide and Child Mortality
Teen suicide and child mortality rates have increased sharply since the 2016 Report, according to the United Health Foundation’s 2019 America’s Health Rankings® Health of Women and Children Report. The Report finds the teen suicide rate and child mortality rate rising over the past three years.
- Zacks
Here's How Cigna (CI) is Poised Amid Political Uncertainty
Growth in health services, government business and international markets drive Cigna's (CI) stock.
- Zacks
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
UnitedHealth Group (UNH) closed the most recent trading day at $234.43, moving +0.35% from the previous trading session.
- Business Wire
UnitedHealth Group Named to Dow Jones Sustainability North America and World Indices for 21st Consecutive Year
UnitedHealth Group has been named to the Dow Jones Sustainability North America Index and the Dow Jones Sustainability World Index for 2019 in the Health Care Equipment & Services Sector.
- Yahoo Finance
Startup uses remittances to remove 'time and distance' from health care
Hoy Health launched less than two years ago, but sees strong growth potential in paving the way to the Latin American health care market.
- GuruFocus.com
US Indexes Close Mostly Lower on Friday
Dow Jones reports its 8th consecutive gain Continue reading...
- InvestorPlace
Dow Jones Today: Lacking Sizzle
Stocks meandered for much of Friday despite some encouraging consumer data, which may not be surprising given that this week was mostly impressive for riskier assets.Source: Shutterstock In a report out earlier today, the University of Michigan's initial reading of September consumer sentiment jumped to 92 from the three-year low of 89.8 last month. Additionally, another report out this morning showed retail sales in August rose 0.4% and that the July reading was revised higher."The resilient reading shows American consumers may be poised to shake off trade war and global slowdown to support the record-long economic expansion as the labor market holds up," according to Bloomberg.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Discount Retail Stocks to Buy for a Recession In recent months, I've noted many times in this space the importance of the U.S. consumer and that many of the recession calls were likely premature because the market has not absorbed material deterioration in consumer data to date. I'll stick by that thesis because the preliminary September sentiment reading seems to indicate the August result was a bump in the road, not the start of a negative trend.Today, the Nasda Composite finished lower by 0.22% while the S&P 500 dropped 0.08%. The Dow Jones Industrial Average was up 0.13%, extending its winning streak to eight days. In late trading, 16 of the Dow's 30 components were pointed higher. Pleasant Surprise for Dow Component UNHIt was interesting if not surprising to see UnitedHealth (NYSE:UNH), a frequent guest of this space, rank as one of the best-performing names in the Dow today. I say surprising because there was a democratic debate last night, an event that typically weighs on stocks like UNH. I missed the goings on, but I'll assume whatever Medicare For All talk that took place was not strident enough to derail UNH shares today.Staying with the healthcare theme, don't read too much into today's bounce in pharmacy name Walgreens Boots Alliance (NASDAQ:WBA), a consumer staples name with sizable drug price exposure, because two of the Dow's three pharmaceuticals names finished lower today. This is another hot-button issue investors need to be aware of going forward."An ambitious draft plan from House Speaker Nancy Pelosi (D-Calif.) to allow government price negotiation on a swath of expensive drugs has shifted Washington's contentious policy debate leftward at a critical point for Democratic negotiations with Senate Republicans and the White House," reports Modern Healthcare. BA Flying HigherBoeing (NYSE:BA) continued trending higher, gaining 1.06% today as the company makes progress toward getting the 737 MAX jet airborne again. A deeper analysis of that issue and other important points on Boeing stock is available here.There seems to be some momentum for Boeing getting the jet back in the skies before the end of this year, Wall Street's desired time horizon, but by the company's admission, it doesn't control the timeline."The timeline is in the hands of divided regulators around the world who must approve Boeing's proposed software fix for 737 MAX flight controls and new training materials. European regulators plan their own test flights on the changes," reports Reuters. Fighting BackWith a decline of about 2%, Apple (NASDAQ:AAPL) was the worst-performing stock in the Dow Jones Industrial Average. That's not something that happens very often, so when it does, it's fair to surmise there's a reason for the Apple weakness, albeit temporary.Goldman Sachs analyst Rod Hall cut his price target on Apple shares today to $165 from $187, saying the company's recently unveiled $4.99 per month price on the Apple + streaming TV service is aggressive and could hamper the company's earnings.Apple rebutted the analyst, saying it doesn't expect Apple + to materially impact results. Bottom Line on Dow JonesThere are just a couple of weeks left in the the third quarter, meaning another earnings season is fast-approaching. I'll leave you with a glance at some of the sectors analysts are bullish and tepid on this quarter."At the sector level, analysts are most optimistic on the Energy (66%) sector, as this sector has the highest percentage of Buy ratings. It is interesting to note that the Energy sector is projected to report the largest earnings decline of all 11 sectors in CY 2019 (-20.9%) and the largest earnings growth of all 11 sectors in CY 2020 (30.2%)," said FactSet.The research firm notes analysts are not enthusiastic about consumer staples as that sector has the lowest percentage of "buy" ratings and the highest percentage of "sell" calls.Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Big IPO Stocks From 2019 to Watch * 7 Discount Retail Stocks to Buy for a Recession * 7 Stocks to Buy Benefiting From Millennial Money The post Dow Jones Today: Lacking Sizzle appeared first on InvestorPlace.
- MarketWatch
Dow's nearly 75-point climb led by gains for shares of UnitedHealth, Dow Inc.
Behind strong returns for shares of UnitedHealth and Dow Inc., the Dow Jones Industrial Average is trading up Friday morning. The Dow (DJIA) was most recently trading 71 points, or 0.3%, higher, as shares of UnitedHealth (UNH) and Dow Inc. (DOW) are contributing to the blue-chip gauge's intraday rally. UnitedHealth's shares are up $6.41, or 2.8%, while those of Dow Inc. are up $0.54, or 1.2%, combining for a roughly 47-point boost for the Dow.
- American City Business Journals
UnitedHealthcare’s Techstars accelerator announces its first class of startups
UnitedHealthcare’s first class of startups are addressing issues like quality of care, access to care and gaps in care.
- Zacks
Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb
Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb
- InvestorPlace
Why Teladoc (TDOC) Stock is Poised to Capture the Future of Healthcare
There's a big shift going on in the healthcare industry. I'm sure you've seen evidence of it yourself. But today, I want to make sure it's on your radar as an investment. My pick in this area, Teladoc (NYSE:TDOC) stock, is starting to take off, and once you see why, you'll want to be on board, too.Healthcare companies are finally joining us here in the 21st century… by using technology to offer us better care, more efficiently.There are all sorts of advancements being made, from DNA sequencing to "liquid biopsies" (which can detect disease biomarkers with one little prick). But the one I find most exciting right now is telemedicine. Rather than getting stuck in line, waiting to see a doctor, these days you can often just log on (or get on the phone) for a "virtual checkup."InvestorPlace - Stock Market News, Stock Advice & Trading TipsI'm a bit of a hypochondriac, so I'm never hesitant to go to urgent care if I'm concerned about something - but I hate sitting in a crowded room with people coughing on me. I'm sure you do, too. Telemedicine is perfect for me, and I've loved it every time I've used it. * 10 Stocks to Sell in Market-Cursed September Aside from convenience, I believe telemedicine could have a big impact on things like mental health. When people are able to see a therapist or psychiatrist virtually, it makes it much easier for people to get treatment.Those are just two anecdotal examples. But as the trend takes hold, more data becomes available. Last week, UnitedHealth Group (NYSE:UNH) published the following research: * Of 5,000 respondents to an Advisory Board survey on telemedicine, three-quarters said they'd consider virtual care. * Telemedicine can be especially important in preventative care. Ninety percent of respondents said they'd cancel (or reschedule) a "wellness visit" if it conflicted with work. * One of the biggest opportunities is in rural areas without sufficient access to healthcare. There are 7,200 of these areas in the United States, in which about 85 million Americans are underserved. * And for health insurers, these programs could save $6 billion annually. For example, a $1,800 trip to the emergency room could cost less than $50 virtually!So far, the results are encouraging: From 2014 to 2018, virtual care usage is up 624%!As for United Healthcare itself, its experience with telemedicine reinforces my expectation that this trend is here to stay. Demographics Are On Their SideUnited Healthcare launched "Virtual Visits" in 2016. Of roughly 500,000 customers to date, "most are between the ages of 30 to 34 and are primarily women."And this generation - the millennials - is now the largest living adult generation, having just surpassed even the baby boomers.This demographic shift is one I have a close eye on. In fact, I just devoted my September issue of Investment Opportunities to it.Millennials are now reaching the point where they're beginning to form families and buy houses. They may have waited longer than their forerunners, but they will have a huge impact as they dominate the economy for the next decade or more.And if millennials prefer virtual checkups, then this really is the future of healthcare. One Company Has the First-Mover AdvantageAt the end of its report, United Healthcare announced that its new, nationwide provider of Virtual Visits is Teladoc.But Teladoc has actually been around since 2002. And today, it's the leading provider of telehealth medical visits in the United States. The company boasts being able to connect you with a licensed doctor in under 10 minutes… whether it's via the phone, internet, or mobile app.Shares got hit on news that Teladoc's contract ran out with the U.S. Defense Health Agency. I wasn't too worried, though, as I explained in Investment Opportunities - where we've owned TDOC stock for a year and a half.Teladoc is already the leader in the telehealth industry, with well over 50% of the market share in the United States. If it can keep growing at this pace, the number of visits could grow by 10-fold in the coming years - and revenue gains should keep pace.Already in the most recent quarter, revenue gained 38% quarter-over-quarter to $130.3 million. Visit volumes soared 70% to 908,000, while U.S. paid memberships grew by 100,000 to 26.8 million.Sure enough, the stock has begun to surge again after the United Healthcare deal was announced. After all, the Military Health System was a 9.4 million-person market - but United Healthcare is a 49.5 million-person market!TDOC stock has popped more than 50% from its lows late last year. It is still under my recommended buy price in Investment Opportunities… but I don't expect it to stay that way for long. Once more investors catch on to the virtual-medicine mega-trend - and identify Teladoc as the industry leader - TDOC stock will realize plenty more upside.And while Teladoc is a great direct play on personalized medicine… Certain Indirect Plays Are Just as InterestingWearable devices are helping people like me take control of our health. The Apple Watch is actually an approved medical device. It can alert you to a low heart rate, detect your heart rhythm, and even conduct an ECG (or EKG). It can also make an emergency call for you - and it can do it in 150 different countries with the new Series 5 announced today.It's no wonder Apple (NASDAQ:AAPL) would want to move into this market: Analysts are predicting 14X growth in just 10 years!All of these devices need to be powered. And when we're talking about something as crucial as medical devices - then we really need a battery that's more reliable than the current technology.It blows my mind that we are STILL relying on battery technology that was created for Sony camcorders in the 1980s. But the next generation is in the works. And these batteries will be more powerful - and much safer.I've got everything you need to know, and I can show you how to invest now. Click here for my free briefing.Matthew McCall left Wall Street to actually help investors -- by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post Why Teladoc (TDOC) Stock is Poised to Capture the Future of Healthcare appeared first on InvestorPlace.
- Zacks
Could the Trade War be Bullish for Stocks?
Tariffs, tweets, negotiations, the Fed cutting rates, full employment, a manufacturing slowdown: how investors can cut through the noise.
- Zacks
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, UnitedHealth Group (UNH) closed at $232.46, marking a +0.77% move from the previous day.
- InvestorPlace
VIDEO: Check Out Teledoc Stock Before Checking in at the Doctor’s
As we enter the second full week of September make sure you have a tissues on hand and football on TV. Oh, and don't forget to keep taking financial news with a grain of salt. In this episode of Matt McCall's "Money Line" podcast, he gives you the basics to get through everything this month has to offer (think cold season, NFL and an often-dreaded market period).If you're cozying up to watch -- or listen to -- this podcast with tissues, cough drops and a bad case of the sniffles, you'll find that McCall is in the same boat. However, his advice for getting through cold season doubles as a stock pick.Do you hate going to the doctor when all you need is a prescription for an antibiotic? Find yourself avoiding appointments to not take time off from work? Telemedicine might just be the answer. For McCall, this meant he could video chat with a doctor, discuss his cold symptoms and pick up a prescription in a matter of minutes. For you, this could mean saving time and escaping the misery of waiting rooms. Telemedicine consultations can cover topics ranging from prenatal care to oncology to dermatology.InvestorPlace - Stock Market News, Stock Advice & Trading TipsMcCall sees Teladoc Health (NYSE:TDOC) as one of the perfect plays for the future of medicine. According to UnitedHealth (NYSE:UNH), 70% of people are willing to or have already tried telemedicine. These survey results are promising for TDOC stock, but a new deal with UnitedHealth may be even more promising. Later this month, Teladoc will become the national virtual visit provider within UnitedHealth's network. This spells good things for TDOC stock and for sniffly workers. McCall's PodcastSeptember isn't just the start of cold season. It also marks the start of the NFL's regular season -- and what's historically considered one of the worst months in the market. Tune in to this episode to get tips on how to handle this dreaded month. * 7 Best Tech Stocks to Buy Right Now McCall's VIP subscribers might know that he's picked four "NFL stocks" to watch. He thinks these are positioned to benefit from the U.S. Supreme Court's May 2018 decision to reverse the Professional and Amateur Sports Protection Act. This law made it illegal to wager on single-game results anywhere other than in Nevada. Only a handful of states have jumped on the betting bandwagon, but McCall thinks that by 2022 it will be every state.If you join him in getting ahead of the trend, there may be huge upside ahead. Just look at the recent deal between Buffalo Wild Wings and MGM Resorts (NYSE:MGM). Now patrons can place bets at the table through a handy smartphone app.Tune in to "Money Line" for more of McCall's analysis on TDOC stock, his call on the future of sports betting and his calming words as September continues to unfold.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post VIDEO: Check Out Teledoc Stock Before Checking in at the Doctor's appeared first on InvestorPlace.
- InvestorPlace
7 Upcoming IPOs for September
As expected, August was fairly slow for IPOs, which happens every year during the summer holidays.There were only seven deals in the month and all but one rose in value. Among the top performers were Inmode (NASDAQ:INMD), up 87% and Kura Sushi USA (NASDAQ:KRUS), which gained 60%.Which company lost money? It was Sundial Growers (NASDAQ:SNDL), which dropped 30% from its debut.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Sell in Market-Cursed September So what should you expect for upcoming IPOs in September? Well, as should be no surprise, there will continue to be offerings from red-hot areas like cloud software operators, and there will be some deals from traditional companies. First: What's an IPO, Anyway?For many people, IPOs are kind of a mystery. After all, it does seem kind of strange for a company's stock to zoom on the first day of trading, right?Here's a quick explanation of IPOs: An IPO is when a company issues its shares to the public on an exchange, such as the Nasdaq Composite or New York Stock Exchange (NYSE). Often this process results in raising a large amount of money, say over $100 million.Getting to this point is not easy. Upcoming IPOs need to have audited books, a strong financial infrastructure and an experienced management team. There will also need to be advisors -- called investment bankers or underwriters -- who will provide guidance through the process. This involves putting together a disclosure document called an S-1, and having a roadshow, in which management makes presentations to investors.Advisors will generally undervalue the shares, allowing for the pop. It's a way to reward investors. Yet these investors are usually institutions, hedge funds, and wealthy people.Yes, it's kind of unfair, but the system has seen little change over the decades. Despite this, individual investors have still made lots of money from IPOs like Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG) and Facebook (NASDAQ:FB) -- regardless of if they got the shares at the offering price.Let's take a look at the seven upcoming IPOs for the month: SmileDirectClub (SDC)Source: Thamyris Salgueiro / Shutterstock.com Among the upcoming IPOs, SmileDirectClub might garner the most interest. This company is the pioneer of the direct-to-consumer market for teeth straightening systems. SmileDirectClub leverages innovative teledentistry technology and has a fully integrated platform.While a orthodontist may charge $5,000 to $8,000 for a procedure, SmileDirectClub charges generally below $2,000. The company also has a financing program and reimbursement relationships with UnitedHealth Group (NYSE:UNH) and CVS Health (NYSE:CVS).From fiscal 2017 to 2019, revenues soared nearly 200% to $423.2 million. And since 2014, the company has served over 700,000 customers. * 7 Tech ETFs to Invest In Now The SmileDirectClub IPO is expected to involve the issuance of 58.5 million shares at a range of $19 to $22. The lead underwriters include JPMorgan (NYSE:JPM), Bank of America (NYSE:BAC), Jefferies, UBS (NYSE:UBS) and Credit Suisse (NYSE:CS). The shares will be listed on the Nasdaq under the ticker of SDC. Cloudflare (NET)Source: Shutterstock Cloudflare develops technologies to deliver highly robust and secure internet connectivity. The company is trying to disrupt the traditional approaches, which rely heavily on legacy on-premise software.From 2016 to 2018, revenues have gone from $84.8 million to $192.7 million. Keep in mind that the company counts 10% of the Fortune 1,000 as paying customers. In fact, about 18% of the top 10,000 websites use at least one product from Cloudflare.As for the upcoming IPO, the company expects to offer 35 million shares at a range of $10 to $12 on the NYSE (the proposed ticker is NET). The lead underwriters are Goldman Sachs (NYSE:GS), Morgan Stanley (NYSE:MS), JPM, Jefferies, Wells Fargo (NYSE:WFC) and RBC. Datadog (DDOG)Source: Shutterstock For upcoming IPOs, Datadog is likely to be red-hot. The company is a developer of technologies for monitoring and analytics for cloud systems. Some of the benefits include IT migration, collaboration, the acceleration of time-to-market for apps and better problem resolution.Founded in 2010, Datadog has been highly capital-efficient. It has raised $92 million - and still has $63.6 million in the bank.What's more, last year revenues shot up 97% to $198.1 million. The company has about 8,800 customers, up from 5,400 on a year-over-year basis. * The 8 Worst Stocks to Buy Before the Trade Turmoil Cools Off Datadog plans to issue 24 million shares at $19 to $22 and the lead underwriters include MS, GS, JPM, CS, Barclays (NYSE:BCS), Jefferies, and RBC. The company will list its shares on the Nasdaq under the ticker of DDOG. Ping Identity Holding (PING)Source: Shutterstock Ping Identity builds technologies that allow for secure access to any web service or API from any device. At the core of this is sophisticated AI (Artificial Intelligence) and ML (Machine Learning) that analyzes data in real-time, whether from the cloud, hybrid cloud, or on-premise systems.In terms of growth, the company's revenues have jumped from $172.5 million in 2017 to $201.6 million in 2018, up about 17%. More than half of the Fortune 100 use the software.Ping Identity IPO expects to issue 12.5 million shares at a range of $14 to $16 and the lead underwriters include GS, BAC, RBC, Citigroup (NYSE:C), BCS, CS, Deutsche Bank (NYSE:DB) and WFC. The company will list on the NYSE under the ticker of PING. Envista Holdings (NVST)Source: Shutterstock Envista is one of the largest dental product companies, with strong positions in categories like implants, digital imaging, and orthodontics. The company owns a variety of brands like Nobel Biocare Systems, Ormco and KaVo Kerr. They have over one million dentists across 150 countries. Last year, Envista posted revenues of $2.86 billion.A key to the success of the company is a strong focus on innovation. To this end, it spent about $172 million on R&D last year. * 10 Buy-and-Hold Stocks to Own Forever Regarding the upcoming IPO, Envista plans to issue 26.8 million shares at a range of $21 to $24 and the lead underwriters include JPM, GS, MS, Baird, Evercore ISI and Jefferies. The company will list on the NYSE under the symbol of NVST. 10x Genomics (TXG)Source: Shutterstock 10X Genomics develops instruments, consumables, and software to help analyze biological systems at scale, such as for oncology, immunology, and neuroscience.Last year, revenues spiked from $71.1 million to $146.3 million. The company also has an extensive intellectual property portfolio, with ownership or exclusive licenses on over 175 patents (about 470 are pending).As for this upcoming IPO, 10X Genomic expects to offer 9 million shares at a range of $31 to $35 and the underwriters include JPM, GS, and BAC. The company will list its shares on the Nasdaq under the ticker of TXG. SpringWorks Therapeutics (SWTX)Source: Shutterstock SpringWorks Therapeutics is a biotech company, which is focused on precision medicine to create oncology treatments. By leveraging partnerships - such as with Pfizer (NYSE:PFE) -- the company has been able to get two drugs into late-stage trials. For example, Nirogacestat is an oral GSI (gamma secretase inhibitor) that is for desmoid tumors (there are no FDA approved drugs for this).In terms of the IPO, the company expects to offer 7.4 million shares at a range of $16 to $18 and the lead underwriters include JPM, GS and Cowen. SpringWorks Therapeutics will list its shares on the Nasdaq under the ticker SWTX.Tom Taulli is the author of the book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post 7 Upcoming IPOs for September appeared first on InvestorPlace.
- Business Wire
Top Health and Aging Organizations Kick Off National Medicare Education Week with Free Events and Resources to Help Simplify Medicare Enrollment
Educational community meetings and online resources support Medicare beneficiaries, their families and caregivers during annual National Medicare Education Week, Sept. 15-21
- Simply Wall St.
Here's What We Like About UnitedHealth Group Incorporated (NYSE:UNH)'s Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Zacks
Centene's Unit, Canopy Health Extend Ties to Improve Care
Centene's (CNC) subsidiary Health Net extends collaboration with Canopy Health to cater wider reach to its CaIPERS members.
- Morningstar
Investing With Our 2020 Healthcare Policy Outlook
Although it's a frequent refrain on the campaign trail, we think Medicare for All or similar policies promising universal coverage are unlikely to see success over the next decade. After analyzing the policy positions of the leading candidates seeking the Democratic Party presidential nomination in 2020, the U.S. Senate landscape in the upcoming election, and the preferences of likely voters on both sides of the aisle, we think investors should consider the probability that a policy similar to Medicare for All will see success to be in the 5%-10% range at best. Aside from the political barriers to broader support of a universal healthcare system, cost remains a key hurdle.
- GuruFocus.com
Top 6 Holdings of Jeremy Grantham's GMO
Firm’s largest holdings include Microsoft and Berkshire position Apple Continue reading...
- Zacks
Ensign Group Acquires Nursing Facility to Expand in Idaho
Ensign Group (ENSG) purchases the real estate and the operations of Temple View Transitional Care Center in Idaho to boost its presence in the state.
- Zacks
Humana (HUM) Ties Up to Boost Medicare Advantage Network
Humana (HUM) collaborates with Iora Health to strengthen its Medicare Advantage network across Texas, Georgia and Arizona.
- Zacks
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, UnitedHealth Group (UNH) closed at $226.79, marking a -1.66% move from the previous day.
- Morningstar
Ultimate Stock-Pickers' Top 10 Buys and Sells
For the past decade, our primary goal with Ultimate Stock-Pickers has been to uncover investment ideas our equity analysts and top investment managers find attractive, in a manner timely enough for investors to gain some value. As part of this process, we scour the quarterly (in some cases, the monthly) holdings of 26 different investment managers: 22 managers oversee mutual funds covered by Morningstar's manager research group and four Stock-Pickers run the investment portfolios of large insurance companies. In our last article, we walked through the Ultimate Stock-Pickers' purchasing activity during the second quarter of 2019.
